Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Levoleucovorin | hsa00190 | Oxidative phosphorylation | 3.27E-02 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Levoleucovorin | hsa00230 | Purine metabolism | 4.02E-02 | 2 | P31350, P21589 | RRM2, NT5E | More | | Levoleucovorin | hsa00240 | Pyrimidine metabolism | 2.54E-04 | 3 | P31350, P21589, P04818 | RRM2, NT5E, TYMS | More | | Levoleucovorin | hsa00280 | Valine, leucine and isoleucine degradation | 2.75E-02 | 4 | P55809, Q9HCC0, Q02252, P11310 | OXCT1, MCCC2, ALDH6A1, ACADM | More | | Levoleucovorin | hsa00600 | Sphingolipid metabolism | 4.56E-02 | 3 | Q9BX95, Q06136, P06280 | SGPP1, FVT1, GLA | More | | Levoleucovorin | hsa00670 | One carbon pool by folate | 3.62E-02 | 1 | P00374 | DHFR | More | | Levoleucovorin | hsa00790 | Folate biosynthesis | 3.62E-02 | 1 | P00374 | DHFR | More | | Levoleucovorin | hsa01100 | Metabolic pathways | 1.66E-02 | 31 | Q9Y234, O14521, P15144, Q99707, P11310, P27707, Q13370, P36959, Q13956, P22748, P55809, P06280, P30043, Q02252, O60701, O14772, O95954, Q9HCC0, P33121, P04406, Q96EB6, O15466, P36551, Q9BX95, P09960, Q9P2R7, Q9UHY7, P35573, Q13488, Q16718, Q02809 | LIPT1, SDHD, ANPEP, MTR, ACADM, DCK, PDE3B, GMPR, PDE6H, CA4, OXCT1, GLA, BLVRB, ALDH6A1, UGDH, FPGT, FTCD, MCCC2, ACSL1, GAPDH, SIRT1, ST8SIA5, CPOX, SGPP1, LTA4H, SUCLA2, ENOPH1, AGL, TCIRG1, NDUFA5, PLOD1 | More | | Levoleucovorin | hsa01523 | Antifolate resistance | 6.06E-03 | 2 | Q92820, P04818 | GGH, TYMS | More | | Levoleucovorin | hsa03013 | RNA transport | 2.29E-04 | 12 | O14980, P52298, Q09161, O14893, P61326, Q7Z3B4, P35658, Q14152, O75822, P78345, Q14240, Q9Y6A5 | XPO1, NCBP2, NCBP1, GEMIN2, MAGOH, NUP54, NUP214, EIF3A, EIF3J, RPP38, EIF4A2, TACC3 | More | | Levoleucovorin | hsa04015 | Rap1 signaling pathway | 2.26E-02 | 3 | P25116, Q8TEU7, P08514 | F2R, RAPGEF6, ITGA2B | More | | Levoleucovorin | hsa04022 | cGMP-PKG signaling pathway | 1.05E-02 | 3 | P24844, Q8WYR1, Q15746 | MYL9, PIK3R5, MYLK | More | | Levoleucovorin | hsa04024 | cAMP signaling pathway | 1.40E-02 | 3 | P48058, P25116, P24844 | GRIA4, F2R, MYL9 | More | | Levoleucovorin | hsa04064 | NF-kappa B signaling pathway | 2.83E-02 | 8 | P10415, Q13489, O00463, Q13546, Q9UDY8, Q13077, Q16548, P24522 | BCL2, BIRC3, TRAF5, RIPK1, MALT1, TRAF1, BCL2A1, GADD45A | More | | Levoleucovorin | hsa04071 | Sphingolipid signaling pathway | 1.03E-02 | 6 | P21453, Q9H228, Q16537, Q9BX95, Q16539, P10415 | S1PR1, EDG8, PPP2R5E, SGPP1, MAPK14, BCL2 | More | | Levoleucovorin | hsa04110 | Cell cycle | 2.34E-02 | 3 | P06493, O60566, P33981 | CDK1, BUB1B, TTK | More | | Levoleucovorin | hsa04115 | p53 signaling pathway | 3.34E-02 | 2 | P31350, P06493 | RRM2, CDK1 | More | | Levoleucovorin | hsa04145 | Phagosome | 2.33E-02 | 7 | O75015, Q15075, Q15080, P14598, Q13509, Q13488, O60603 | FCGR3B, EEA1, NCF4, NCF1, TUBB3, TCIRG1, TLR2 | More | | Levoleucovorin | hsa04270 | Vascular smooth muscle contraction | 4.65E-02 | 2 | Q15746, P24844 | MYLK, MYL9 | More | | Levoleucovorin | hsa04510 | Focal adhesion | 3.36E-02 | 3 | P08514, Q15746, P24844 | ITGA2B, MYLK, MYL9 | More | | Levoleucovorin | hsa04512 | ECM-receptor interaction | 2.44E-02 | 2 | P07359, P08514 | GP1BA, ITGA2B | More | | Levoleucovorin | hsa04514 | Cell adhesion molecules | 4.65E-02 | 2 | P16109, O00501 | SELP, CLDN5 | More | | Levoleucovorin | hsa04530 | Tight junction | 7.42E-04 | 4 | Q8TEU7, O00501, Q14247, P24844 | RAPGEF6, CLDN5, CTTN, MYL9 | More | | Levoleucovorin | hsa04610 | Complement and coagulation cascades | 2.94E-02 | 2 | P25116, P10909 | F2R, CLU | More | | Levoleucovorin | hsa04611 | Platelet activation | 1.59E-05 | 5 | P25116, P08514, Q15746, Q8WYR1, P07359 | F2R, ITGA2B, MYLK, PIK3R5, GP1BA | More | | Levoleucovorin | hsa04613 | Neutrophil extracellular trap formation | 7.45E-03 | 12 | O60603, P05164, P08246, Q9UM07, Q92769, Q6FI13, Q15080, O75015, P21730, P21462, O43315, Q16539 | TLR2, MPO, ELA2, PADI4, HDAC2, H2AC18; H2AC19, NCF4, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Levoleucovorin | hsa04668 | TNF signaling pathway | 4.96E-02 | 6 | O00463, Q13546, Q13489, Q16539, Q13077, P14780 | TRAF5, RIPK1, BIRC3, MAPK14, TRAF1, MMP9 | More | | Levoleucovorin | hsa04724 | Glutamatergic synapse | 2.94E-02 | 2 | P48058, Q9NSB8 | GRIA4, HOMER2 | More | | Levoleucovorin | hsa04810 | Regulation of actin cytoskeleton | 1.38E-03 | 4 | P24844, Q15746, P08514, P25116 | MYL9, MYLK, ITGA2B, F2R | More | | Levoleucovorin | hsa04921 | Oxytocin signaling pathway | 6.37E-03 | 3 | Q15746, P24844, Q8WYR1 | MYLK, MYL9, PIK3R5 | More | | Levoleucovorin | hsa05034 | Alcoholism | 2.79E-02 | 2 | P62879, Q9BTM1 | GNB2, H2AFJ | More | | Levoleucovorin | hsa05130 | Pathogenic Escherichia coli infection | 2.51E-02 | 3 | Q14247, O00501, P25116 | CTTN, CLDN5, F2R | More | | Levoleucovorin | hsa05200 | Pathways in cancer | 4.70E-02 | 3 | P17301, P20585, P62879 | ITGA2, MSH3, GNB2 | More | | Levoleucovorin | hsa05202 | Transcriptional misregulation in cancer | 1.61E-03 | 13 | Q15532, P41732, P14780, P27930, Q16548, Q13489, Q13077, P35226, P05164, P08246, Q9C0K0, Q92769, P24522 | SS18, TSPAN7, MMP9, IL1R2, BCL2A1, BIRC3, TRAF1, BMI1, MPO, ELA2, BCL11B, HDAC2, GADD45A | More | | Levoleucovorin | hsa05217 | Basal cell carcinoma | 2.01E-02 | 4 | Q13635, P04628, Q9UJU2, P24522 | PTCH1, WNT1, LEF1, GADD45A | More | | |